TipRanks
Go Ultimate55% OFF

TG Therapeutics (NKB2) Cash flow

TG Therapeutics Cash Flow

CH:NKB2's free cash flow for Q2 2026 was $38.97M. For the 2026 fiscal year, CH:NKB2's free cash flow was decreased by $-293.00K and operating cash flow was $39.26M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -24.77M$ -40.52M$ -31.41M$ -176.17M$ -295.63M
$ 13.80M$ -1.04M$ -50.65M$ -20.01M$ -332.00K
$ -89.73M$ 128.53M$ 72.70M$ -391.00K$ 41.42M
$ 80.49M$ 181.19M$ 94.22M$ 103.58M$ 300.15M
$ -24.99M$ -40.56M$ -31.41M$ -176.18M$ -296.04M

Currency in USD

TG Therapeutics Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing